Close Menu

Biofortuna

The company said that the funds will allow it to take its ReadyPlex rapid blood group genotyping assays into clinical trials and commercialization.

A brief recap of Genetics/Genomics news the week of Oct 7, 2016: SEC, Exact Sciences, Eurofins MWG Operon, Almac Group, California Blood organizations, Stat-Diagnostica, and Biofortuna

The new investment will support an expanding contract business as well as in-house MDx development.

NEW YORK (GenomeWeb) — Citing increased demand from companies outsourcing freeze-drying of diagnostic kits, molecular diagnostics firm Biofortuna has expanded its PCR reagent lyophilization production service.

NEW YORK (GenomeWeb News) — Biofortuna said today that it has received 510(k) clearance from the US Food and Drug Administration for its SSPGo HLA PCR kits.

NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Biofortuna today announced a £1.3 million investment ($2.0 million), which will go toward the expansion of its custom service and manufacturing business.

NEW YORK (GenomeWeb News) – Becton Dickinson said this week it has declared a quarterly dividend of $45 per share, payable on Sept. 28 to shareholders of record on Sept. 7. The indicated annual dividend rate is $1.80 per share.

NEW YORK (GenomeWeb News) – Liverpool, UK-based Biofortuna announced today that it has extended an exclusive distribution agreement with Abbott.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.